Logo image of YAR.OL

YARA INTERNATIONAL ASA (YAR.OL) Stock Fundamental Analysis

OSL:YAR - NO0010208051 - Common Stock

367.35 NOK
-0.05 (-0.01%)
Last: 9/10/2025, 9:26:08 AM
Fundamental Rating

5

Taking everything into account, YAR scores 5 out of 10 in our fundamental rating. YAR was compared to 65 industry peers in the Chemicals industry. YAR has only an average score on both its financial health and profitability. A decent growth rate in combination with a cheap valuation! Better keep an eye on YAR.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year YAR was profitable.
YAR had a positive operating cash flow in the past year.
In the past 5 years YAR has always been profitable.
Each year in the past 5 years YAR had a positive operating cash flow.
YAR.OL Yearly Net Income VS EBIT VS OCF VS FCFYAR.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

1.2 Ratios

The Return On Assets of YAR (4.15%) is better than 67.69% of its industry peers.
YAR has a better Return On Equity (8.70%) than 64.62% of its industry peers.
YAR's Return On Invested Capital of 7.66% is fine compared to the rest of the industry. YAR outperforms 70.77% of its industry peers.
YAR had an Average Return On Invested Capital over the past 3 years of 10.26%. This is above the industry average of 7.08%.
Industry RankSector Rank
ROA 4.15%
ROE 8.7%
ROIC 7.66%
ROA(3y)5.28%
ROA(5y)4.52%
ROE(3y)11.06%
ROE(5y)9.6%
ROIC(3y)10.26%
ROIC(5y)9.83%
YAR.OL Yearly ROA, ROE, ROICYAR.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

Looking at the Profit Margin, with a value of 4.80%, YAR is in the better half of the industry, outperforming 66.15% of the companies in the same industry.
In the last couple of years the Profit Margin of YAR has declined.
YAR has a better Operating Margin (8.66%) than 64.62% of its industry peers.
YAR's Operating Margin has declined in the last couple of years.
The Gross Margin of YAR (27.45%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of YAR has remained more or less at the same level.
Industry RankSector Rank
OM 8.66%
PM (TTM) 4.8%
GM 27.45%
OM growth 3Y-15.9%
OM growth 5Y-3.81%
PM growth 3Y-66.57%
PM growth 5Y-53.53%
GM growth 3Y-0.02%
GM growth 5Y-0.33%
YAR.OL Yearly Profit, Operating, Gross MarginsYAR.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so YAR is still creating some value.
The number of shares outstanding for YAR remains at a similar level compared to 1 year ago.
YAR has less shares outstanding than it did 5 years ago.
The debt/assets ratio for YAR is higher compared to a year ago.
YAR.OL Yearly Shares OutstandingYAR.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
YAR.OL Yearly Total Debt VS Total AssetsYAR.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

YAR has an Altman-Z score of 2.60. This is not the best score and indicates that YAR is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.60, YAR is in line with its industry, outperforming 60.00% of the companies in the same industry.
YAR has a debt to FCF ratio of 7.06. This is a slightly negative value and a sign of low solvency as YAR would need 7.06 years to pay back of all of its debts.
YAR's Debt to FCF ratio of 7.06 is fine compared to the rest of the industry. YAR outperforms 67.69% of its industry peers.
A Debt/Equity ratio of 0.43 indicates that YAR is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.43, YAR is in line with its industry, outperforming 50.77% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 7.06
Altman-Z 2.6
ROIC/WACC0.92
WACC8.36%
YAR.OL Yearly LT Debt VS Equity VS FCFYAR.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

YAR has a Current Ratio of 1.60. This is a normal value and indicates that YAR is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of YAR (1.60) is comparable to the rest of the industry.
YAR has a Quick Ratio of 1.60. This is a bad value and indicates that YAR is not financially healthy enough and could expect problems in meeting its short term obligations.
YAR's Quick ratio of 0.83 is on the low side compared to the rest of the industry. YAR is outperformed by 70.77% of its industry peers.
Industry RankSector Rank
Current Ratio 1.6
Quick Ratio 0.83
YAR.OL Yearly Current Assets VS Current LiabilitesYAR.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 76.02% over the past year.
The earnings per share for YAR have been decreasing by -11.01% on average. This is quite bad
Looking at the last year, YAR shows a small growth in Revenue. The Revenue has grown by 2.93% in the last year.
YAR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.52% yearly.
EPS 1Y (TTM)76.02%
EPS 3Y-22.66%
EPS 5Y-11.01%
EPS Q2Q%111.63%
Revenue 1Y (TTM)2.93%
Revenue growth 3Y-5.85%
Revenue growth 5Y1.52%
Sales Q2Q%11.89%

3.2 Future

YAR is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.16% yearly.
Based on estimates for the next years, YAR will show a small growth in Revenue. The Revenue will grow by 3.95% on average per year.
EPS Next Y128.2%
EPS Next 2Y47.88%
EPS Next 3Y27.34%
EPS Next 5Y2.16%
Revenue Next Year9.39%
Revenue Next 2Y3.67%
Revenue Next 3Y2.83%
Revenue Next 5Y3.95%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
YAR.OL Yearly Revenue VS EstimatesYAR.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B
YAR.OL Yearly EPS VS EstimatesYAR.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

9

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 12.24 indicates a correct valuation of YAR.
YAR's Price/Earnings ratio is rather cheap when compared to the industry. YAR is cheaper than 87.69% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.07, YAR is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 9.74, the valuation of YAR can be described as reasonable.
Based on the Price/Forward Earnings ratio, YAR is valued cheaply inside the industry as 92.31% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.59. YAR is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 12.24
Fwd PE 9.74
YAR.OL Price Earnings VS Forward Price EarningsYAR.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, YAR is valued cheaply inside the industry as 89.23% of the companies are valued more expensively.
YAR's Price/Free Cash Flow ratio is rather cheap when compared to the industry. YAR is cheaper than 81.54% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.88
EV/EBITDA 5.43
YAR.OL Per share dataYAR.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100 200 300 400 500

4.3 Compensation for Growth

YAR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
YAR has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as YAR's earnings are expected to grow with 27.34% in the coming years.
PEG (NY)0.1
PEG (5Y)N/A
EPS Next 2Y47.88%
EPS Next 3Y27.34%

3

5. Dividend

5.1 Amount

YAR has a Yearly Dividend Yield of 1.30%.
YAR's Dividend Yield is comparable with the industry average which is at 3.00.
With a Dividend Yield of 1.30, YAR pays less dividend than the S&P500 average, which is at 2.46.
Industry RankSector Rank
Dividend Yield 1.3%

5.2 History

The dividend of YAR decreases each year by -8.80%.
Dividend Growth(5Y)-8.8%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

YAR pays out 17.97% of its income as dividend. This is a sustainable payout ratio.
DP17.97%
EPS Next 2Y47.88%
EPS Next 3Y27.34%
YAR.OL Yearly Income VS Free CF VS DividendYAR.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B
YAR.OL Dividend Payout.YAR.OL Dividend Payout, showing the Payout Ratio.YAR.OL Dividend Payout.PayoutRetained Earnings

YARA INTERNATIONAL ASA

OSL:YAR (9/10/2025, 9:26:08 AM)

367.35

-0.05 (-0.01%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-18 2025-07-18/bmo
Earnings (Next)10-17 2025-10-17/bmo
Inst Owners42.41%
Inst Owner ChangeN/A
Ins Owners0.07%
Ins Owner ChangeN/A
Market Cap93.58B
Analysts57.86
Price Target386.86 (5.31%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.3%
Yearly Dividend4.73
Dividend Growth(5Y)-8.8%
DP17.97%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)15.06%
Min EPS beat(2)-7.59%
Max EPS beat(2)37.7%
EPS beat(4)2
Avg EPS beat(4)8.26%
Min EPS beat(4)-47.21%
Max EPS beat(4)50.14%
EPS beat(8)4
Avg EPS beat(8)58.19%
EPS beat(12)6
Avg EPS beat(12)23.58%
EPS beat(16)7
Avg EPS beat(16)11.87%
Revenue beat(2)2
Avg Revenue beat(2)0.26%
Min Revenue beat(2)0.19%
Max Revenue beat(2)0.33%
Revenue beat(4)2
Avg Revenue beat(4)-1.54%
Min Revenue beat(4)-3.34%
Max Revenue beat(4)0.33%
Revenue beat(8)2
Avg Revenue beat(8)-6.35%
Revenue beat(12)3
Avg Revenue beat(12)-4.87%
Revenue beat(16)4
Avg Revenue beat(16)-3.72%
PT rev (1m)1.35%
PT rev (3m)6.93%
EPS NQ rev (1m)9.84%
EPS NQ rev (3m)53.66%
EPS NY rev (1m)29.17%
EPS NY rev (3m)29.17%
Revenue NQ rev (1m)4.25%
Revenue NQ rev (3m)13.78%
Revenue NY rev (1m)0.77%
Revenue NY rev (3m)2.88%
Valuation
Industry RankSector Rank
PE 12.24
Fwd PE 9.74
P/S 0.64
P/FCF 15.88
P/OCF 5.82
P/B 1.16
P/tB 1.31
EV/EBITDA 5.43
EPS(TTM)30.01
EY8.17%
EPS(NY)37.73
Fwd EY10.27%
FCF(TTM)23.13
FCFY6.3%
OCF(TTM)63.14
OCFY17.19%
SpS571.29
BVpS315.43
TBVpS281.49
PEG (NY)0.1
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.15%
ROE 8.7%
ROCE 10.03%
ROIC 7.66%
ROICexc 8.2%
ROICexgc 8.85%
OM 8.66%
PM (TTM) 4.8%
GM 27.45%
FCFM 4.05%
ROA(3y)5.28%
ROA(5y)4.52%
ROE(3y)11.06%
ROE(5y)9.6%
ROIC(3y)10.26%
ROIC(5y)9.83%
ROICexc(3y)11.17%
ROICexc(5y)10.65%
ROICexgc(3y)12.02%
ROICexgc(5y)11.5%
ROCE(3y)13.48%
ROCE(5y)12.99%
ROICexcg growth 3Y-20.87%
ROICexcg growth 5Y0.34%
ROICexc growth 3Y-20.66%
ROICexc growth 5Y0.45%
OM growth 3Y-15.9%
OM growth 5Y-3.81%
PM growth 3Y-66.57%
PM growth 5Y-53.53%
GM growth 3Y-0.02%
GM growth 5Y-0.33%
F-Score6
Asset Turnover0.86
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 7.06
Debt/EBITDA 1.5
Cap/Depr 96.69%
Cap/Sales 7%
Interest Coverage 4.9
Cash Conversion 69.5%
Profit Quality 84.31%
Current Ratio 1.6
Quick Ratio 0.83
Altman-Z 2.6
F-Score6
WACC8.36%
ROIC/WACC0.92
Cap/Depr(3y)107.36%
Cap/Depr(5y)98.34%
Cap/Sales(3y)6.55%
Cap/Sales(5y)6.27%
Profit Quality(3y)1242.99%
Profit Quality(5y)807.54%
High Growth Momentum
Growth
EPS 1Y (TTM)76.02%
EPS 3Y-22.66%
EPS 5Y-11.01%
EPS Q2Q%111.63%
EPS Next Y128.2%
EPS Next 2Y47.88%
EPS Next 3Y27.34%
EPS Next 5Y2.16%
Revenue 1Y (TTM)2.93%
Revenue growth 3Y-5.85%
Revenue growth 5Y1.52%
Sales Q2Q%11.89%
Revenue Next Year9.39%
Revenue Next 2Y3.67%
Revenue Next 3Y2.83%
Revenue Next 5Y3.95%
EBIT growth 1Y68.09%
EBIT growth 3Y-20.82%
EBIT growth 5Y-2.34%
EBIT Next Year149.37%
EBIT Next 3Y35.87%
EBIT Next 5Y16.52%
FCF growth 1Y-52.42%
FCF growth 3Y-28.42%
FCF growth 5Y-24.89%
OCF growth 1Y-29.75%
OCF growth 3Y-2.93%
OCF growth 5Y-7.58%